Xia Gu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Pulmonary Hypertension Research and Treatments 3
- Co-authors
- Fanglei Liu (1 shared paper)Zhongliang Guo (1 shared paper)Kai‐Ling Wang (1 shared paper)Dongyi Zhu (1 shared paper)Jingjing Lu (1 shared paper)Qingchun Lu (1 shared paper)Wang Xie (1 shared paper)Ping He (3 shared papers)
In The Last Decade
Xia Gu
33 papers receiving 623 citations
Xia Gu's Hit Papers
Peers
Comparison fields: 5 of 83
- Cancer Research 94
- Pulmonary and Respiratory Medicine 149
- Oncology 99
- Immunology 62
- Geriatrics and Gerontology 9
Countries citing papers authored by Xia Gu
This map shows the geographic impact of Xia Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Gu more than expected).
Fields of papers citing papers by Xia Gu
This network shows the impact of papers produced by Xia Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Gu. The network helps show where Xia Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 135 | |
| 2 | Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma ( NIC‐ESCC2019 ): A multicenter, phase 2 study Hit paper breakdown → | 2022 | 121 |
| 3 | 2019 | 35 | |
| 4 | 2020 | 34 | |
| 5 | 2022 | 30 | |
| 6 | 2016 | 24 | |
| 7 | Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China. | 2014 | 23 |
| 8 | 2021 | 21 | |
| 9 | 2012 | 17 | |
| 10 | 2016 | 17 | |
| 11 | 2013 | 16 | |
| 12 | 2014 | 16 | |
| 13 | 2013 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 11 | |
| 17 | 2020 | 10 | |
| 18 | 2023 | 10 | |
| 19 | 2023 | 8 | |
| 20 | 2023 | 8 |
About Xia Gu
Xia Gu is a scholar working on Pulmonary and Respiratory Medicine, Biochemistry, Reproductive Medicine, Physiology and Immunology, having authored 37 papers that have together received 628 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Adipose Tissue and Metabolism (3 papers), Lung Cancer Treatments and Mutations (3 papers), Endometriosis Research and Treatment (3 papers), Pulmonary Hypertension Research and Treatments (3 papers), Tuberous Sclerosis Complex Research (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Cancer Research (94 citations), Pulmonary and Respiratory Medicine (149 citations), Oncology (99 citations), Immunology (62 citations) and Geriatrics and Gerontology (9 citations). Xia Gu has collaborated with scholars based in China, Japan and Germany. Frequent co-authors include Fanglei Liu, Zhongliang Guo, Kai‐Ling Wang, Dongyi Zhu, Jingjing Lu, Qingchun Lu, Wang Xie, Ping He, Haihong Yang and Jianxing He. Their work appears in journals such as Leukemia, Translational Pediatrics, International Journal of Women s Health, Cancer Science and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.